Active04607142Private limited companyGainsborough

AROMESSE LIMITED

Significant control: Karen Ann Marriott (75–100%), Christopher Bainborough (significant control)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Aromesse Limited sell?

Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

AROMESSE LIMITED is an active private limited company (company number 04607142) incorporated on 3 December 2002, registered in Gainsborough. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 31 December 2024, showing net assets of £322k, with 6 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 3% on the prior period (£313k).

Peer position · net assets

By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).

02

Ownership and control

2 active
  • Miss Karen Ann Marriott
    Individual · since 6 April 2016
    • owns 75–100% of shares
  • Mr Christopher Bainborough
    Individual · since 6 April 2016
    • has significant influence or control

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
3 December 200223 yrs ago
Next accounts due
30 September 202624 days overdue
Confirmation statement due
17 December 2026in 54 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21100
Manufacture of basic pharmaceutical products
Accounts type
Micro Entity
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2024
Net assets
£322k
+3%vs Dec 2023
Cash at bank
Not reported
Turnover
Not disclosed
Employees
6
No changevs Dec 2023
Net assets
£322k
Average employees
6
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024£322k——£35k——6
31 December 2023£313k——£24k——6
Current ratio9.98Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £321,812 at 31 December 2024
  • Current assets at least 1.5× creditors within one yearCurrent ratio 9.98
  • Incorporated five or more years agoIncorporated 3 December 2002
  • Accounts past their due dateDue 30 September 2026

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 54 days
  2. Next accounts due24 days overdue
  3. Accounts period endNet assets £322k · micro accounts
  4. Accounts period endNet assets £313k · micro accounts
  5. Incorporated
08

Similar companies in Sheffield

Same activity (manufacture of basic pharmaceutical products), closest in incorporation date
09

Reminders for AROMESSE LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.